Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.

Nakles RE, Shiffert MT, Díaz-Cruz ES, Cabrera MC, Alotaiby M, Miermont AM, Riegel AT, Furth PA.

Mol Endocrinol. 2011 Apr;25(4):549-63. doi: 10.1210/me.2010-0114. Epub 2011 Feb 3.

PMID:
21292825
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

Tilli MT, Reiter R, Oh AS, Henke RT, McDonnell K, Gallicano GI, Furth PA, Riegel AT.

Mol Endocrinol. 2005 Mar;19(3):644-56. Epub 2004 Nov 18.

PMID:
15550471
[PubMed - indexed for MEDLINE]
3.

The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.

Sampayo R, Recouvreux S, Simian M.

Vitam Horm. 2013;93:185-201. doi: 10.1016/B978-0-12-416673-8.00012-5. Review.

PMID:
23810007
[PubMed - indexed for MEDLINE]
4.

The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.

Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE.

Mol Cancer. 2010 Jun 15;9:150. doi: 10.1186/1476-4598-9-150.

PMID:
20550710
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.

Torres-Arzayus MI, Zhao J, Bronson R, Brown M.

Cancer Res. 2010 May 15;70(10):4102-11. doi: 10.1158/0008-5472.CAN-09-4080. Epub 2010 May 4.

PMID:
20442283
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Expression and localisation of oestrogen and progesterone receptors in the bovine mammary gland during development, function and involution.

Schams D, Kohlenberg S, Amselgruber W, Berisha B, Pfaffl MW, Sinowatz F.

J Endocrinol. 2003 May;177(2):305-17.

PMID:
12740019
[PubMed - indexed for MEDLINE]
Free Article
7.

Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.

Furth PA, Cabrera MC, Díaz-Cruz ES, Millman S, Nakles RE.

Ann N Y Acad Sci. 2011 Jul;1229:147-55. doi: 10.1111/j.1749-6632.2011.06086.x. Review.

PMID:
21793850
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.

Ramamoorthy S, Tufail R, Hokayem JE, Jorda M, Zhao W, Reis Z, Nawaz Z.

Breast Cancer Res Treat. 2012 Feb;132(1):97-108. doi: 10.1007/s10549-011-1567-2. Epub 2011 May 8.

PMID:
21553290
[PubMed - indexed for MEDLINE]
9.

Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.

Kim TH, Lee DK, Cho SN, Orvis GD, Behringer RR, Lydon JP, Ku BJ, McCampbell AS, Broaddus RR, Jeong JW.

Cancer Res. 2013 Aug 15;73(16):5090-9. doi: 10.1158/0008-5472.CAN-13-0241. Epub 2013 Jun 27.

PMID:
23811943
[PubMed - indexed for MEDLINE]
10.

Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.

Ramamoorthy S, Dhananjayan SC, Demayo FJ, Nawaz Z.

Mol Endocrinol. 2010 Nov;24(11):2099-113. doi: 10.1210/me.2010-0116. Epub 2010 Sep 9.

PMID:
20829392
[PubMed - indexed for MEDLINE]
11.

AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.

Kuang SQ, Liao L, Zhang H, Lee AV, O'Malley BW, Xu J.

Cancer Res. 2004 Mar 1;64(5):1875-85.

PMID:
14996752
[PubMed - indexed for MEDLINE]
Free Article
12.

Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Qiu C, Shan L, Yu M, Snyderwine EG.

Carcinogenesis. 2005 Apr;26(4):763-9. Epub 2005 Jan 6.

PMID:
15637090
[PubMed - indexed for MEDLINE]
Free Article
13.

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.

Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD.

Breast Cancer Res. 2012 Jan 20;14(1):R16.

PMID:
22264274
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.

Feng Y, Manka D, Wagner KU, Khan SA.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14718-23. Epub 2007 Sep 4.

PMID:
17785410
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM.

Mol Endocrinol. 2006 Jan;20(1):14-34. Epub 2005 Aug 18.

PMID:
16109739
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.

Reiter R, Wellstein A, Riegel AT.

J Biol Chem. 2001 Oct 26;276(43):39736-41. Epub 2001 Aug 13.

PMID:
11502741
[PubMed - indexed for MEDLINE]
Free Article
17.

Mammary gland development is mediated by both stromal and epithelial progesterone receptors.

Humphreys RC, Lydon J, O'Malley BW, Rosen JM.

Mol Endocrinol. 1997 Jun;11(6):801-11.

PMID:
9171243
[PubMed - indexed for MEDLINE]
18.

Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.

Herynk MH, Lewis MT, Hopp TA, Medina D, Corona-Rodriguez A, Cui Y, Beyer AR, Fuqua SA.

Oncogene. 2009 Sep 10;28(36):3177-87. doi: 10.1038/onc.2009.174. Epub 2009 Jun 29.

PMID:
19561644
[PubMed - indexed for MEDLINE]
19.

Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium.

Shim WS, DiRenzo J, DeCaprio JA, Santen RJ, Brown M, Jeng MH.

Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):208-13.

PMID:
9874797
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.

Balmer NN, Richer JK, Spoelstra NS, Torkko KC, Lyle PL, Singh M.

Mod Pathol. 2006 Dec;19(12):1593-605. Epub 2006 Sep 15.

PMID:
16980945
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk